FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:1238-1243 May 11, 1989 Number 19 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To examine the use of analgesics as a cause of chronic renal disease, we performed a multicenter case-control study of 554 adults with newly diagnosed kidney disease (serum creatinine, greater than or equal to 130 mumol per liter [1.5 mg per deciliter]) and 516 matched control subjects selected randomly from the same area of North Carolina. Histories of use of analgesics (phenacetin, acetaminophen, and aspirin) were obtained by telephone interview with the patients or their proxies. Daily users of analgesics had significantly more renal disease than infrequent users (odds ratio, 2.79; 95 percent confidence interval, 1.85 to 4.21). The risk of renal disease was highest in daily users of phenacetin (odds ratio, 5.11; confidence interval, 1.76 to 14.9, after adjustment for the effects of other analgesics). The risk of renal disease was also increased in daily users of acetaminophen; after adjustment for the use of aspirin and phenacetin, the odds ratio was 3.21 (confidence interval, 1.05 to 9.80). There was no increased risk in daily aspirin users (adjusted odds ratio, 1.32; confidence interval, 0.69 to 2.51). The risks with daily use of either phenacetin or acetaminophen changed little after adjustment for diabetes, hypertension, and the indication for analgesic use. We conclude that the long-term, regular use of phenacetin may increase the risk of chronic renal disease. The long-term, daily use of acetaminophen, the major metabolite of phenacetin, is associated independently with an increased risk of chronic renal disease. We could find no increased risk in daily users of aspirin.

Source Information

Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.

This article has been cited by other articles:

• De Broe, M. E., Elseviers, M. M. (2009). Over-the-Counter Analgesic Use. J. Am. Soc. Nephrol. 20: 2098-2103 [Abstract] [Full Text]  
• Evans, M., Fored, C. M., Bellocco, R., Fitzmaurice, G., Fryzek, J. P., McLaughlin, J. K., Nyren, O., Elinder, C.-G. (2009). Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant 24: 1908-1918 [Abstract] [Full Text]  
• Michielsen, P., Heinemann, L., Mihatsch, M., Schnulle, P., Graf, H., Koch, K.-M. (2009). Non-phenacetin analgesics and analgesic nephropathy: Clinical assessment of high users from a case-control study [1]*. Nephrol Dial Transplant 24: 1253-1259 [Abstract] [Full Text]  
• Ahmed, M. H., Ashton, N., Balment, R. J. (2003). Renal Function in a Rat Model of Analgesic Nephropathy: Effect of Chloroquine. J. Pharmacol. Exp. Ther. 305: 123-130 [Abstract] [Full Text]  
• Courtney, P, Doherty, M (2002). Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis 61: 767-773 [Full Text]  
• Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C.-G., Blot, W. J., McLaughlin, J. K., Zack, M. M., Nyren, O. (2001). Acetaminophen, Aspirin, and Chronic Renal Failure. NEJM 345: 1801-1808 [Abstract] [Full Text]  
• Rexrode, K. M., Buring, J. E., Glynn, R. J., Stampfer, M. J., Youngman, L. D., Gaziano, J. M. (2001). Analgesic Use and Renal Function in Men. JAMA 286: 315-321 [Abstract] [Full Text]  
• Anthony, J. C., Breitner, J. C. S., Zandi, P. P., Meyer, M. R., Jurasova, I., Norton, M. C., Stone, S. V. (2000). Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study. Neurology 54: 2066-2071 [Abstract] [Full Text]  
• Fox, J. M., Schwarz, A. (1999). Doubts about a particularly high nephrotoxicity of combination analgesics. Nephrol Dial Transplant 14: 2966-2968 [Full Text]  
• De Broe, M. E., Elseviers, M. M. (1998). Analgesic Nephropathy. NEJM 338: 446-452 [Full Text]  
• Verlander, J. W. (1998). Normal Ultrastructure of the Kidney and Lower Urinary Tract. Toxicol Pathol 26: 1-17 [Abstract]  
• Bach, P. H., Thanh, N. T. K. (1998). Renal Papillary Necrosis--40 Years On. Toxicol Pathol 26: 73-91 [Abstract]  
• Griffin, M. R., Brandt, K. D., Liang, M. H., Pincus, T., Ray, W. A. (1995). Practical Management of Osteoarthritis: Integration of Pharmacologic and Nonpharmacologic Measures. Arch Fam Med 4: 1049-1055 [Abstract]  
• Perneger, T. V., Whelton, P. K., Klag, M. J. (1994). Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs. NEJM 331: 1675-1679 [Abstract] [Full Text]  
• Ronco, P. M., Flahault, A. (1994). Drug-Induced End-Stage Renal Disease. NEJM 331: 1711-1712 [Full Text]  
• Powars, D. R., Elliott-Mills, D. D., Chan, L., Niland, J., Hiti, A. L., Opas, L. M., Johnson, C. (1991). Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality. ANN INTERN MED 115: 614-620 [Abstract]  
• Sandler, D. P., Burr, F. R., Weinberg, C. R. (1991). Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease. ANN INTERN MED 115: 165-165 [Abstract]  
• Wagner, E. H. (1991). Nonsteroidal Anti-Inflammatory Drugs and Renal Disease--Still Unsettled. ANN INTERN MED 115: 227-228 [Abstract]  
• Mitchell, S. R. (1991). Tell Your Kidneys to Take a Powder. Arch Intern Med 151: 617-617 [Abstract]  
• Abuelo, J. G. (1990). Renal Failure Caused by Chemicals, Foods, Plants, Animal Venoms, and Misuse of Drugs: An Overview. Arch Intern Med 150: 505-510 [Abstract]  
• (1989). ANALGESICS AND CHRONIC RENAL FAILURE. JWatch General 1989: 2-2 [Full Text]